5Bedry R, Baudrimont I, Deflleux G, et al. Wild-mushroom intcofication as a cause of rhabdomyolysis[ J ]. N Engl J Med, 2001,345 ( 11 ) : 798-802. 被引量：1
6Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysia[ J]. Medicine, 1982,61 (3) : 141-152. 被引量：1
8Herd JA, Ballantyne CM, Farmer JA, et al. Effects of fluvastatin on coronary ather-osclerosis in patients with mild to moderate cholesterol elevations ( Lipoprotein and Coronary Athero- sclerosis Study [ LCAS] )[J]. Am J Cardiol, 1997,80(3) :278-286. 被引量：1
9Omar MA, Wilson JP, Cox TS. Rhabdomyolysis and HMG-CoA reductare inhibi-tom[ J]. Ann Pharm,2001,35(9) : 1096-1105. 被引量：1
10Oken DE, Arce ML, Wilson DR. Glycerol-induced hemoglobinuric acute renal failfure in the rat. I. Micropuncture study of the development of oliguria[ J ]. J Clin Invest, 1966,45 ( 5 ) : 724-735. 被引量：1
2Schlienger JL, Goichot B, Grunenberger F, et al. Thyroid myopathy dis- closed by a fibrate. Rev Med Interne, 1997, 18:169. 被引量：1
3GUAYDR. Micronized fenofibrate : a new fibric acid hypolipidemica- gent. Ann Pharmacother , 1999 , 33 (10) :1083. 被引量：1
4Blane GF. Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives. Am J Med JT - The American journal of medicine, 1987,83:26. 被引量：1
